MURUGAPPAN M, BABU B, SHANKAR V, YUSUF M, and JAWAHAR N, “ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT”, Asian J Pharm Clin Res, vol. 18, no. 4, pp. 44–51, Apr. 2025.